Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2006

01-09-2006 | Original Article

Evaluation of a Gastrointestinal Symptoms Questionnaire

Authors: H. J. Bovenschen, M. J. R. Janssen, M. G. H. van Oijen, R. J. F. Laheij, L. G. M. van Rossum, J. B. M. J. Jansen

Published in: Digestive Diseases and Sciences | Issue 9/2006

Login to get access

Abstract

Questionnaires are widely used instruments to monitor gastrointestinal (GI) symptoms. However, few of these questionnaires have been formally evaluated. We sought to evaluate our GI symptoms questionnaire in terms of clarity and reproducibility. Primary care patients referred for open access Helicobacter pylori urea breath testing reported GI symptoms (type+severity) and demographic information by written questionnaire. In an interview, patients gave a personal description of the meaning of the GI symptoms on the questionnaire. Patients’ descriptions of GI symptoms were compared with current definitions. Symptom severity scores were compared before and after, interview versus questionnaire. Of the 45 patients included, 19 (42%) described all symptoms correctly, whereas 17 (38%) described one symptom incorrectly. None of the patients made more than three mistakes. Regurgitation was the most common incorrectly described symptom (16 patients [36%]), whereas the other individual symptoms were well explained. Symptom severities before the interview, after the interview and reported by questionnaire (mean value±SEM) were 2.1 ± 0.2, 2.1 ± 0.2, and 1.5 ± 0.2 points on a 7-point Likert scale (0–6), respectively. Mean severity reported by interview (95% CI) was 1.4 (1.3–1.5) times higher than reported by questionnaire (P < .05). In conclusion, the GI symptom questionnaire is understandable and has good reproducibility for measuring the presence of GI symptoms, although symptom severity is consistently rated higher when reported by interview.
Literature
1.
go back to reference Knill-Jones RP: Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 26 (Suppl 182):17–24 1991CrossRef Knill-Jones RP: Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 26 (Suppl 182):17–24 1991CrossRef
2.
go back to reference Garatt AM, Ruta DA, Russell I, MacLeod K, Brunt P, McKinlay A, Mowat A, Sinclair T: Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms. J Clin Epidemiol 49:565–571 1996CrossRef Garatt AM, Ruta DA, Russell I, MacLeod K, Brunt P, McKinlay A, Mowat A, Sinclair T: Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms. J Clin Epidemiol 49:565–571 1996CrossRef
3.
go back to reference Malfertheiner P: Current concepts in dyspepsia: a world perspective. Eur J Gastroenterol Hepatol 11 (Suppl 1):S25–29 1999PubMed Malfertheiner P: Current concepts in dyspepsia: a world perspective. Eur J Gastroenterol Hepatol 11 (Suppl 1):S25–29 1999PubMed
4.
go back to reference Guillemot F, Ducrotte P, Bueno L: Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice. Gastroenterol Clin Biol 29:243–246 2005PubMedCrossRef Guillemot F, Ducrotte P, Bueno L: Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice. Gastroenterol Clin Biol 29:243–246 2005PubMedCrossRef
5.
go back to reference Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ: Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 47:449–454 1998PubMedCrossRef Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ: Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 47:449–454 1998PubMedCrossRef
6.
go back to reference Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I: Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 30:1046–1052 1995PubMedCrossRef Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I: Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 30:1046–1052 1995PubMedCrossRef
7.
go back to reference Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels A, Escobedo S, Chakraborty B, Sinclair P, Veldhuyzen van Zanten SJO: The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment—prompt endoscopy (CADET-PE) study. Aliment Pharmacol Ther 17:1481–1491 2003PubMedCrossRef Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels A, Escobedo S, Chakraborty B, Sinclair P, Veldhuyzen van Zanten SJO: The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment—prompt endoscopy (CADET-PE) study. Aliment Pharmacol Ther 17:1481–1491 2003PubMedCrossRef
8.
go back to reference Ofman JJ, Shaw M, Sadik K, Grogg A, Emery K, Lee J, Reyes E, Fullerton S: Identifying patients with gastroesophageal reflux disease: validation of a practical screening tool. Dig Dis Sci 47:1863–1869 2002PubMedCrossRef Ofman JJ, Shaw M, Sadik K, Grogg A, Emery K, Lee J, Reyes E, Fullerton S: Identifying patients with gastroesophageal reflux disease: validation of a practical screening tool. Dig Dis Sci 47:1863–1869 2002PubMedCrossRef
9.
go back to reference Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H: International validation of ReQuestTM in patients with endoscopy-negative gastro-oesophageal reflux disease. Aliment Pharmacol Ther 20:891–898 2004PubMedCrossRef Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H: International validation of ReQuestTM in patients with endoscopy-negative gastro-oesophageal reflux disease. Aliment Pharmacol Ther 20:891–898 2004PubMedCrossRef
10.
go back to reference Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H: Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuestTM. Digestion 69:229–237 2004PubMedCrossRef Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H: Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuestTM. Digestion 69:229–237 2004PubMedCrossRef
11.
go back to reference Kuykendall DH, Rabeneck L, Campbell JM, Wray NP: Dyspepsia: how should we measure it? J Clin Epidemiol 51:99–106 1998PubMedCrossRef Kuykendall DH, Rabeneck L, Campbell JM, Wray NP: Dyspepsia: how should we measure it? J Clin Epidemiol 51:99–106 1998PubMedCrossRef
12.
go back to reference Kennedy T, Jones R: Development of a postal health status questionnaire to identify people with dyspepsia in the general population. Scand J Prim Health Care 13:243–249 1995PubMedCrossRef Kennedy T, Jones R: Development of a postal health status questionnaire to identify people with dyspepsia in the general population. Scand J Prim Health Care 13:243–249 1995PubMedCrossRef
13.
go back to reference Agréus L, Svärdsudd K, Nyrén O, Tibblin G: Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care 11:252–262 1993PubMedCrossRef Agréus L, Svärdsudd K, Nyrén O, Tibblin G: Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care 11:252–262 1993PubMedCrossRef
14.
go back to reference Österberg A, Graf W, Karlbom U, Pahlman L: Evaluation of a questionnaire in the assessment of patients with faecal incontinence and constipation. Scand J Gastroenterol 31:575–580 1996PubMedCrossRef Österberg A, Graf W, Karlbom U, Pahlman L: Evaluation of a questionnaire in the assessment of patients with faecal incontinence and constipation. Scand J Gastroenterol 31:575–580 1996PubMedCrossRef
15.
go back to reference Talley NJ, Phillips SF, Melton L3rd , Wiltgen C, Zinsmeister AR: A patient questionnaire to identify bowel disease. Ann Intern Med 111:671–674 1989PubMed Talley NJ, Phillips SF, Melton L3rd , Wiltgen C, Zinsmeister AR: A patient questionnaire to identify bowel disease. Ann Intern Med 111:671–674 1989PubMed
16.
go back to reference Ruth M, Finizia C, Lundell L: Occurrence and future history of oesophageal symptoms in an urban Swedish population: Results of a questionnaire-based, ten-year follow-up study. Scand J Gastroentrerol 40:629–635 2005CrossRef Ruth M, Finizia C, Lundell L: Occurrence and future history of oesophageal symptoms in an urban Swedish population: Results of a questionnaire-based, ten-year follow-up study. Scand J Gastroentrerol 40:629–635 2005CrossRef
17.
go back to reference DiBaise JK: A randomized, double-blind comparison of two different coffee-roasting processes on development of heartburn and dyspepsia in coffee-sensitive individuals. Dig Dis Sci 48:652–656 2003PubMedCrossRef DiBaise JK: A randomized, double-blind comparison of two different coffee-roasting processes on development of heartburn and dyspepsia in coffee-sensitive individuals. Dig Dis Sci 48:652–656 2003PubMedCrossRef
Metadata
Title
Evaluation of a Gastrointestinal Symptoms Questionnaire
Authors
H. J. Bovenschen
M. J. R. Janssen
M. G. H. van Oijen
R. J. F. Laheij
L. G. M. van Rossum
J. B. M. J. Jansen
Publication date
01-09-2006
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9120-6

Other articles of this Issue 9/2006

Digestive Diseases and Sciences 9/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.